Nazara Technologies Ltd
NAZARANazara Technologies Ltd is cheap for a reason. The P/E sits at the 2nd percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: the P/E sits at the 2nd percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn.
The price is in a confirmed uptrend (14 weeks in) while the P/E sits at the 2nd percentile of its own 5-year range. Underneath, the last four quarters read deteriorating — profit −260.8% year on year, and 147% of the last 3 years' profit arrived as cash. What settles it: whether the quarters turn before the discount closes.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Nazara Technologies Ltd trades at ₹370, in a confirmed uptrend and 14 weeks into that stage. That is +23.5% against its own 200-day average. It sits at 97% of a 52-week range of ₹226 to ₹375. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 9 straight weeks.
Today the stock is in a confirmed uptrend — week 14 of stage 2, confirmed. At ₹370 it trades +23.5% versus its 200-day average and sits at 97% of its 52-week range (₹226–₹375).
Against the market, two honest reads. Cumulative: over the last 5.4 years the stock moved +77% while the NIFTY 500 moved +83% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 9 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Nazara Technologies Ltd trades at 11.6× P/E, about the cheapest it has ever traded. Its long-run median P/E is 95.5×, measured across 4.7 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 11.6× is about the cheapest it has ever traded, against a long-run median of 95.5× measured over 4.7 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +19.9% against a +35.0% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the +19.1%/yr price move, ~+155.8%/yr came from earnings growth and ~−136.7 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
The PEG ratio and its quarterly curve, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 86% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Nazara Technologies Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE lifting at 27.0% — the per-curve reads carry the story. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +12.6% | +18.8% | +32.1% | +24.1% |
| Profit | +60.8% | +10.4% | +42.4% | +2.4% |
| EPS | +19.9% | +20.2% | +46.8% | −24.0% |
| Share price | +35.0% | +19.1% | +10.7% | — |
4-Factor Sector Score
60.5/100 — rank 5 of 25 in Entertainment & Media · 79% evidence confidence
Nazara Technologies Ltd scores 60.5 out of 100 against the 25 companies it is compared with in Entertainment & Media, ranking 5. Price leads the evidence: RS versus the benchmark is 33.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
The four contributions add to the total exactly: 11.9 + 15.8 + 13.1 + 19.7 = 60.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Nazara Technologies Ltd reported ₹429 Cr of revenue in the Jun 26 quarter, −14.0% year on year. Over 10 years it has compounded at 24.1% a year. The last full year, FY26, came in at ₹1,829 Cr. The last four reported quarters add to ₹1,759 Cr.
FY26 revenue came in at ₹1,829 Cr (+12.6% on the year), capping 10 years at 24.1% compound. The latest quarter (Jun 26) printed ₹429 Cr, −14.0% year on year.
Pace check: the last four quarters averaged +0.8% growth against the decade's 24.1% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −6.1% over the last 4 quarters against +24.6%/yr over the last 8 — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Nazara Technologies Ltd's operating margin is −9.0% in the Jun 26 quarter, −13.7 percentage points against the same quarter a year ago. Across 11 fiscal years the operating margin has ranged −3.0% to 36.0%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is −9.0%, −13.7 pp against the same quarter a year ago. Across 11 fiscal years the operating margin has ranged −3.0%–36.0%.
🚨 Why the margin moved: operating margin went −13.5 pp year on year while gross margin went +1.2 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Nazara Technologies Ltd posted a net loss of ₹82.0 Cr in the Jun 26 quarter. Full-year FY26 profit was ₹82.0 Cr. The 10-year compound rate is 2.4%. That loss is 19.1% of the quarter's revenue. The same quarter a year earlier earned ₹51.0 Cr. 2 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹−82.0 Cr, −260.8% year on year. On the full year, FY26 printed ₹82.0 Cr (+60.8%), and the 10-year compound rate is 2.4%.
🚨 Why profit moved: revenue contributed −14.0% and the margin −13.7 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +172.8% vs revenue +0.8%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 147% of Nazara Technologies Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹149 Cr of operating cash against ₹82.0 Cr of profit. After ₹−41.0 Cr of capital spending, ₹190 Cr was left as free cash.
FY26: operating cash of ₹149 Cr against reported profit of ₹82.0 Cr, leaving free cash of ₹190 Cr after ₹−41.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 147% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 147%: the cash cycle stretched 20 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 3.1× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Nazara Technologies Ltd's cash conversion cycle runs 75 days in FY26, up from 55 days in FY21. Capital spending ran ₹1,306 Cr over the last 3 years. At FY26 sales of ₹1,829 Cr each day of that cycle holds about ₹5.0 Cr, so roughly ₹376 Cr sits inside the business at any moment.
FY26: debtors at 75 days (an asset-light business — no inventory to speak of) — for a full cycle of 75 days, looser than FY21's 55.
In money terms: at FY26 sales of ₹1,829 Cr, each day of the cycle holds about ₹5.0 Cr — so the 75-day loop keeps roughly ₹376 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹1,306 Cr over the last 3 fiscal years against ₹416 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹42.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Nazara Technologies Ltd earns a ROCE of 27% in FY26. That is up from a trough of −4% in FY20. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 4.5% net margin on 0.42× asset turns.
FY26 ROCE is 27%, recovered from a FY20 trough of −4% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 4.5% net margin × 0.42× asset turns × 1.25× balance-sheet leverage ≈ 2.4% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 86% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Nazara Technologies Ltd carries ₹215 Cr of borrowings against ₹3,473 Cr of equity in FY26, a debt-to-equity of 0.06. Operating profit covers the interest bill −1×. Over 5 years borrowings went from ₹1.0 Cr to ₹215 Cr. Capital spending ran ₹1,306 Cr across the last 3 of those years.
FY26: borrowings of ₹215 Cr against equity of ₹3,473 Cr — a debt-to-equity of 0.06. Operating profit covers the interest bill −1×. Over 5 years borrowings went from ₹1.0 Cr to ₹215 Cr while capital spending ran ₹1,306 Cr in just the last 3 — part of the build-out is riding on borrowed money.
The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 86% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 25.0 points of Nazara Technologies Ltd over 8 quarters, the biggest move on the register. That takes promoters to 34.0% of the company. Domestic institutions moved −11.0 points over the same window, to 2.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +25.0 points over 8 quarters to 34.0%; Domestic institutions: −11.0 points over 8 quarters to 2.5%; Foreign institutions: +3.9 points over 8 quarters to 15.5%.
Why the register moved: rotation — foreign institutions +3.9 points against domestic institutions −11.0 points over 8 quarters, with promoters +25.0 points — one class of institutions handing the register to the other, not a verdict change by the people closest to the numbers.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Nazara Technologies Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Nila Spaces LtdNILASPACES | 71.2/100Favorable setup81% evidence | TURNING | 28.5/35 Revenue 31.1% · PAT 75.5% · OPM change 9.1 pp 95% evidence | 20.0/25 ROCE 31.3% · OPM 38.7% 95% evidence | 11.6/20 P/E 15.5× · PEG — 50% evidence | 11.1/20 RS sector 4% · RS bench -13.6% · 1Y -17.4%0 of 6 weeks ahead 70% evidence |
| Exact sum: 28.5 + 20 + 11.6 + 11.1 = 71.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2PVR Inox LtdPVRINOX | 69.3/100Favorable setup91% evidence | BREAKING OUT | 23.3/35 Revenue 13.7% · PAT 100% · OPM change 5 pp 74% evidence | 10.5/25 ROCE 6.8% · OPM 33% 100% evidence | 16.9/20 P/E 38.3× · PEG 0.71 100% evidence | 18.6/20 RS sector 24.4% · RS bench 19.1% · 1Y 7.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 10.5 + 16.9 + 18.6 = 69.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Prime Focus LtdPFOCUS | 65.6/100Favorable setup83% evidence | BREAKING OUT | 26.3/35 Revenue 29.2% · PAT 100% · OPM change 0 pp 100% evidence | 11.6/25 ROCE 11.3% · OPM 24% 100% evidence | 9.1/20 P/E 136× · PEG — 15% evidence | 18.6/20 RS sector 32.4% · RS bench 27.5% · 1Y 96.3%4 of 12 weeks ahead 100% evidence |
| Exact sum: 26.3 + 11.6 + 9.1 + 18.6 = 65.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Hindustan Media Ventures LtdHMVL | 63.1/100Mixed-positive evidence72% evidence | FADING | 23.2/35 Revenue 10.8% · PAT 2.3% · OPM change 8 pp 95% evidence | 15.1/25 ROCE 11.5% · OPM 14% 95% evidence | 13.1/20 P/E 3.7× · PEG — 50% evidence | 11.7/20 RS sector — · RS bench 7.2% · 1Y —7 of 9 weeks ahead 25% evidence |
| Exact sum: 23.2 + 15.1 + 13.1 + 11.7 = 63.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Nazara Technologies Ltdthis pageNAZARA | 60.5/100Mixed-positive evidence79% evidence | LEADER | 11.9/35 Revenue -6.1% · PAT -80% · OPM change -13.7 pp 95% evidence | 15.8/25 ROCE 27.1% · OPM -9% 76% evidence | 13.1/20 P/E — · PEG — 35% evidence | 19.7/20 RS sector 39.2% · RS bench 33.4% · 1Y 34.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 11.9 + 15.8 + 13.1 + 19.7 = 60.5 · Decision use: Price leads the evidence: RS versus the benchmark is 33.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 6H T Media LtdHTMEDIA | 56.7/100Mixed-positive evidence79% evidence | BREAKING OUT | 18.4/35 Revenue 4.1% · PAT -80% · OPM change 9.9 pp 71% evidence | 8.6/25 ROCE 6.3% · OPM 7% 95% evidence | 13.7/20 P/E 4.8× · PEG — 50% evidence | 16.0/20 RS sector 10.8% · RS bench 5.8% · 1Y -4.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 8.6 + 13.7 + 16 = 56.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Sun TV Network LtdSUNTV | 54.9/100Mixed-positive evidence100% evidence | BASING | 18.2/35 Revenue 12.7% · PAT -8.6% · OPM change 2 pp 100% evidence | 18.7/25 ROCE 16.4% · OPM 50% 100% evidence | 12.7/20 P/E 11.9× · PEG 1.37 100% evidence | 5.3/20 RS sector -8.1% · RS bench -12% · 1Y -14.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.2 + 18.7 + 12.7 + 5.3 = 54.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8City Pulse Multiventures Ltd542727 | 54.4/100Mixed-positive evidence65% evidence | 22.4/35 Revenue 100% · PAT 100% · OPM change -166.4 pp 83% evidence | 11.3/25 ROCE 2.6% · OPM 78.6% 76% evidence | 8.7/20 P/E 268× · PEG — 15% evidence | 12.0/20 RS sector 41.4% · RS bench -87.3% · 1Y -88.6%0 of 5 weeks ahead to 2026-08-09 70% evidence | |
| Exact sum: 22.4 + 11.3 + 8.7 + 12 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Basilic Fly Studio LtdBASILIC | 52.6/100Mixed-positive evidence70% evidence | 13.4/35 Revenue — · PAT — · OPM change -3 pp 45% evidence | 21.0/25 ROCE 22.3% · OPM 21% 95% evidence | 14.4/20 P/E 9.5× · PEG — 50% evidence | 3.8/20 RS sector -29.6% · RS bench -34.7% · 1Y -59.3%1 of 7 weeks ahead to 2026-08-09 100% evidence | |
| Exact sum: 13.4 + 21 + 14.4 + 3.8 = 52.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 10Media Matrix Worldwide LtdMMWL | 51.7/100Mixed-positive evidence80% evidence | BREAKING OUT | 15.3/35 Revenue -23.2% · PAT 100% · OPM change -0.5 pp 95% evidence | 10.7/25 ROCE 9.8% · OPM 1.5% 95% evidence | 8.8/20 P/E 215× · PEG — 15% evidence | 16.9/20 RS sector 22.3% · RS bench 16.8% · 1Y 4.4%8 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 10.7 + 8.8 + 16.9 = 51.7 · Decision use: Price leads the evidence: RS versus the benchmark is 16.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11Zee Media Corporation LtdZEEMEDIA | 44.5/100Mixed-negative evidence72% evidence | ASLEEP | 20.7/35 Revenue 22.3% · PAT 98.3% · OPM change -2 pp 71% evidence | 10.1/25 ROCE 5.3% · OPM 9% 95% evidence | 9.0/20 P/E 144× · PEG — 15% evidence | 4.7/20 RS sector -10.2% · RS bench -14.4% · 1Y -39.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.7 + 10.1 + 9 + 4.7 = 44.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Panorama Studios International LtdPANORAMA | 43.4/100Mixed-negative evidence69% evidence | 10.4/35 Revenue -23.7% · PAT -53.7% · OPM change 5 pp 95% evidence | 12.5/25 ROCE 8.7% · OPM 11% 76% evidence | 9.6/20 P/E 58× · PEG — 15% evidence | 10.9/20 RS sector -4.5% · RS bench 18.5% · 1Y 10.2%0 of 12 weeks ahead 70% evidence | |
| Exact sum: 10.4 + 12.5 + 9.6 + 10.9 = 43.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Balaji Telefilms LtdBALAJITELE | 40.4/100Mixed-negative evidence64% evidence | TURNING | 14.5/35 Revenue 0.8% · PAT -80% · OPM change 24 pp 71% evidence | 6.0/25 ROCE -9.5% · OPM 11% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.9/20 RS sector -3.9% · RS bench -8.5% · 1Y -17.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 14.5 + 6 + 10 + 9.9 = 40.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Hathway Cable & Datacom LtdHATHWAY | 38.4/100Mixed-negative evidence87% evidence | ASLEEP | 12.6/35 Revenue 5.7% · PAT -28.3% · OPM change -4 pp 95% evidence | 8.0/25 ROCE 2.6% · OPM 13% 95% evidence | 9.3/20 P/E 23.9× · PEG — 50% evidence | 8.5/20 RS sector -6.2% · RS bench -10.8% · 1Y -30%3 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 8 + 9.3 + 8.5 = 38.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Dish TV India LtdDISHTV | 38.1/100Mixed-negative evidence69% evidence | BASING | 14.2/35 Revenue -23.8% · PAT -71.9% · OPM change -63 pp 71% evidence | 12.4/25 ROCE 70% · OPM -41% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 1.5/20 RS sector -23.8% · RS bench -27.7% · 1Y -53.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 14.2 + 12.4 + 10 + 1.5 = 38.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Network 18 Media & Investments LtdNETWORK18 | 36.9/100Mixed-negative evidence66% evidence | ASLEEP | 17.3/35 Revenue -48.5% · PAT 97.8% · OPM change 0.5 pp 95% evidence | 5.6/25 ROCE 3% · OPM 1.4% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.0/20 RS sector -24.1% · RS bench -27.4% · 1Y -50.7%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.3 + 5.6 + 10 + 4 = 36.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Den Networks LtdDEN | 35.9/100Mixed-negative evidence81% evidence | TURNING | 10.4/35 Revenue -2.3% · PAT -29.8% · OPM change -3.3 pp 95% evidence | 7.0/25 ROCE 3.2% · OPM 4.7% 95% evidence | 11.4/20 P/E 8.7× · PEG — 50% evidence | 7.1/20 RS sector -10.2% · RS bench -7.2% · 1Y -25%1 of 10 weeks ahead 70% evidence |
| Exact sum: 10.4 + 7 + 11.4 + 7.1 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18T.V. Today Network LtdTVTODAY | 34.0/100Adverse evidence81% evidence | TURNING | 12.1/35 Revenue -7.8% · PAT -43.3% · OPM change 5.9 pp 95% evidence | 8.1/25 ROCE 4.5% · OPM 8% 95% evidence | 7.9/20 P/E 23.9× · PEG — 50% evidence | 5.9/20 RS sector -17.6% · RS bench -11.1% · 1Y -28.2%2 of 10 weeks ahead 70% evidence |
| Exact sum: 12.1 + 8.1 + 7.9 + 5.9 = 34 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Zee Entertainment Enterprises LtdZEEL | 31.4/100Adverse evidence94% evidence | ASLEEP | 6.0/35 Revenue 2.4% · PAT -71.5% · OPM change -8 pp 100% evidence | 6.5/25 ROCE 2.7% · OPM 5% 100% evidence | 13.4/20 P/E 36.4× · PEG 0.28 100% evidence | 5.5/20 RS sector -15.8% · RS bench -15.9% · 1Y -31.5%7 of 10 weeks ahead 70% evidence |
| Exact sum: 6 + 6.5 + 13.4 + 5.5 = 31.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 20Entertainment Network (India) LtdENIL | 31.1/100Adverse evidence73% evidence | 13.7/35 Revenue 3.9% · PAT -80% · OPM change 1.5 pp 71% evidence | 3.9/25 ROCE -0.8% · OPM 7.9% 95% evidence | 5.5/20 P/E 364× · PEG — 50% evidence | 8.0/20 RS sector -3.2% · RS bench -18.6% · 1Y -35.5%0 of 5 weeks ahead to 2026-08-09 70% evidence | |
| Exact sum: 13.7 + 3.9 + 5.5 + 8 = 31.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21GTPL Hathway LtdGTPL | 30.4/100Adverse evidence81% evidence | BASING | 10.2/35 Revenue 8.3% · PAT -80% · OPM change -1.5 pp 95% evidence | 10.6/25 ROCE 3.5% · OPM 10.3% 95% evidence | 6.0/20 P/E 84.3× · PEG — 50% evidence | 3.6/20 RS sector -31% · RS bench -21.6% · 1Y -48.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 10.2 + 10.6 + 6 + 3.6 = 30.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22New Delhi Television LtdNDTV | 27.9/100Adverse evidence69% evidence | ASLEEP | 10.4/35 Revenue 12.1% · PAT -39.6% · OPM change -4 pp 71% evidence | 1.6/25 ROCE -72.6% · OPM -58% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.9/20 RS sector -9.3% · RS bench -13.7% · 1Y -35.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 10.4 + 1.6 + 10 + 5.9 = 27.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Bright Outdoor Media Ltd543831 | 61.4/100Thin evidence · provisional48% evidence | 20.2/35 Revenue 50.9% · PAT 100% · OPM change 1 pp 27% evidence | 16.6/25 ROCE 15.7% · OPM 23% 57% evidence | 9.2/20 P/E 43.7× · PEG — 50% evidence | 15.4/20 RS sector 22.3% · RS bench 17.4% · 1Y 17.9%12 of 12 weeks ahead to 2026-04-05 70% evidence | |
| Exact sum: 20.2 + 16.6 + 9.2 + 15.4 = 61.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Amagi Media Labs LtdAMAGI | 52.7/100Thin evidence · provisional38% evidence | BREAKING OUT | 23.1/35 Revenue — · PAT — · OPM change 7.4 pp 45% evidence | 10.3/25 ROCE 8% · OPM 7% 76% evidence | 9.3/20 P/E 125× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence |
| Exact sum: 23.1 + 10.3 + 9.3 + 10 = 52.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25DAPS Advertising Ltd543651 | 50.7/100Thin evidence · provisional43% evidence | 17.9/35 Revenue — · PAT — · OPM change 0.7 pp 15% evidence | 12.7/25 ROCE 9.9% · OPM 5.4% 57% evidence | 13.9/20 P/E 8.5× · PEG — 50% evidence | 6.2/20 RS sector -20.1% · RS bench -6.2% · 1Y -18.2%0 of 10 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 17.9 + 12.7 + 13.9 + 6.2 = 50.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Nazara Technologies Ltd's share price today?
Nazara Technologies Ltd trades at ₹370, +35.0% over the past year. The company is valued at ₹14,212 Cr. The stock sits at 97% of its 52-week range of ₹226–₹375, +23.5% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 14 weeks in. — as of 11 September 2026.
What were Nazara Technologies Ltd's latest quarterly results?
Nazara Technologies Ltd reported revenue of ₹429 Cr and a net loss of ₹82.0 Cr for the Jun 26 quarter. Revenue fell 14.0% and profit fell 260.8% year on year. Earnings per share were ₹−2.16. The operating margin was −9.0%, 13.7 pp lower than a year earlier. — as of 11 September 2026.
What is Nazara Technologies Ltd's revenue?
Nazara Technologies Ltd reported revenue of ₹429 Cr in the Jun 26 quarter, −14.0% year on year. For the full FY26 fiscal year, revenue was ₹1,829 Cr (+12.6%). Over the last 10 years revenue compounded at 24.1% a year. — as of 11 September 2026.
What is Nazara Technologies Ltd's profit?
Nazara Technologies Ltd earned ₹−82.0 Cr of net profit in the Jun 26 quarter, −260.8% year on year. Full-year FY26 profit was ₹82.0 Cr. The operating margin ran −9.0% in the latest quarter. — as of 11 September 2026.
What is Nazara Technologies Ltd's market cap?
Nazara Technologies Ltd's market capitalisation is ₹14,212 Cr at a share price of ₹370. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Nazara Technologies Ltd's P/E ratio?
Nazara Technologies Ltd trades at a P/E of 11.6×, at the 2nd percentile of its own 5-year range, against a long-run median of 95.5×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Nazara Technologies Ltd pay a dividend?
Not in its latest year — Nazara Technologies Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 1 of its last 11 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Nazara Technologies Ltd overvalued?
On its own history, Nazara Technologies Ltd looks cheap: its P/E of 11.6× has been cheaper only 2% of the time in 5 years (long-run median 95.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Nazara Technologies Ltd growing?
Not right now — Nazara Technologies Ltd's latest numbers are shrinking: latest-quarter revenue −14.0% year on year, profit −260.8%, and the margin −13.7 pp at −9.0%. The 10-year compound rates are 24.1% (revenue) and 2.4% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is Nazara Technologies Ltd performing?
Nazara Technologies Ltd is in a confirmed uptrend, 14 weeks in. Its latest quarter's revenue fell 14.0% and profit fell 260.8% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 9 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Nazara Technologies Ltd in?
Mixed — no clean majority across the growth curves, ROCE lifting at 27.0% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth −6.1% latest, profit growth −160.0% latest, eps growth −138.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Nazara Technologies Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 14 of stage 2), trading +23.5% versus its 200-day average and at 97% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Nazara Technologies Ltd beating the market?
On recent form, yes — Nazara Technologies Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 9 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 5.4 years the stock moved +77% against the NIFTY 500's +83% — behind the index over the full window. — as of 11 September 2026.
Will Nazara Technologies Ltd's share price go up?
This page publishes no price forecast for Nazara Technologies Ltd. What it measures instead: the share price is ₹370, the price is in a confirmed uptrend 14 weeks in. Its P/E of 11.6× sits at the 2nd percentile of its own 5-year range. — as of 11 September 2026.
Who owns Nazara Technologies Ltd?
Promoters hold 34.0% of Nazara Technologies Ltd, foreign institutions 15.5%, domestic institutions 2.5% and the public 48.0% (latest quarter). The biggest move on the register over the last two years: Promoters added 25.0 points over 8 quarters. — as of 11 September 2026.
Does Nazara Technologies Ltd have too much debt?
No — Nazara Technologies Ltd's debt-to-equity is 0.06, and operating profit covers the interest bill −1×. FY26 borrowings were ₹215 Cr against equity of ₹3,473 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.
What is Nazara Technologies Ltd's capex?
Nazara Technologies Ltd spent ₹1,306 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹−41.0 Cr, with ₹42.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Nazara Technologies Ltd's cash flow?
Nazara Technologies Ltd generated ₹149 Cr of operating cash flow in FY26 and ₹190 Cr of free cash flow after ₹−41.0 Cr of capital spending. Reported profit that year was ₹82.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Nazara Technologies Ltd's profit real cash?
Yes — over the last 3 fiscal years, 147% of Nazara Technologies Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹149 Cr against reported profit of ₹82.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Nazara Technologies Ltd in its business cycle?
Nazara Technologies Ltd's FY26 operating margin was −1.5%, against a 11-year band of −3.0%–36.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran −9.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the Nazara Technologies Ltd story?
The sharpest disagreement: the P/E sits at the 2nd percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Nazara Technologies Ltd a stock worth studying right now?
This is not investment advice. The machine read: Nazara Technologies Ltd is cheap for a reason. The P/E sits at the 2nd percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the quarters turn before the discount closes. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!